Cognition Therapeutics Inc (NASDAQ: CGTX) kicked off on Friday, up 8.39% from the previous trading day, before settling in for the closing price of $1.43. Over the past 52 weeks, CGTX has traded in a range of $0.22-$3.83.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -16.44%. While this was happening, its average annual earnings per share was recorded 53.20%. With a float of $70.92 million, this company’s outstanding shares have now reached $88.22 million.
Cognition Therapeutics Inc (CGTX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cognition Therapeutics Inc is 19.61%, while institutional ownership is 5.95%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.25 earnings per share (EPS), lower than consensus estimate (set at -0.21) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.20% per share during the next fiscal year.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Take a look at Cognition Therapeutics Inc’s (CGTX) current performance indicators. Last quarter, stock had a quick ratio of 1.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
Compared to the last year’s volume of 4.77 million, its volume of 2.21 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 78.07%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 36.80%, which indicates a significant decrease from 51.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1582 in the past 14 days, which was higher than the 0.1549 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6295, while its 200-day Moving Average is $0.7751. Nevertheless, the first resistance level for the watch stands at $1.6300 in the near term. At $1.7100, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8100. If the price goes on to break the first support level at $1.4500, it is likely to go to the next support level at $1.3500. Now, if the price goes above the second support level, the third support stands at $1.2700.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
The company with the Market Capitalisation of 136.75 million has total of 73,524K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -33,970 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,730 K.
